No abstract available
Keywords:
Chronic myelogenous leukemia; Moyamoya disease; Nilotinib.
MeSH terms
-
Antineoplastic Agents* / therapeutic use
-
Chronic Disease
-
Humans
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
-
Moyamoya Disease*
-
Pyrimidines / therapeutic use
-
Treatment Outcome
Substances
-
Pyrimidines
-
Antineoplastic Agents